Apigenin has been reported to exert angiogenic and anticancer activities in vitro. The mechanism of inhibition of angiogenesis by apigenin, however, has not been well-established. In this study, we investigated whether apigenin not only inhibited tube formation but also induced apoptosis in human umbilical vein endothelial cells (HUVECs). Furthermore, strong antiangiogenic activity of apigenin was observed in the in vivo assay using chick embryo chorioallantoic membrane (CAM). We also analyzed changes in survival signals and the apoptotic pathway through Western blotting. The results indicate that apigenin exerts its antiangiogenic effects through induction of endothelial apoptosis.
JanssenK., MensinkR.P., CoxF.J., HarryvanJ.L., HovenierR., HollmanP.C., KatanM.B. (1998) Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study. American Journal of Clinical Nutrition, 67, 255–262.
2.
AhnM.R., KunimasaK., KumazawaS., NakayamaT., KajiK., UtoY., HoriH., NagasawaH., OhtaT. (2009) Correlation between antiangiogenic activity and antioxidant activity of various components from propolis. Molecular Nutrition and Food Research, 53, 643–651.
3.
HussainA.R., KhanA.S., AhmedS.O., AhmedM., PlataniasL.C., AI-KurayaK.S., UddinS. (2010) Apigenin induces apoptosis via downregulation of S-phase kinase-associated protein 2-mediated induction of p27Kip1 in primary effusion lymphoma cells. Cell Proliferation, 43, 170–183.
4.
SilvanS., ManoharanS., BaskaranN., AnusuyaC., KarthikeyanS., PrabhakarM.M. (2011) Chemopreventive potential of apigenin in 7,12–dimethylbenz(a)anthracene induced experimental oral carcinogenesis. European Journal of Pharmacology, 30, 571–577.
5.
WangW., HeidemanL., ChungC.S., PellingJ.C., KoehlerK.J., BirtD.F. (2000) Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines. Molecular Carcinogenesis, 28, 102–110.
6.
CaltagironeS., RossiC., PoggiA., RanellettiF.O., NataliP.G., BrunettiM., AielloF.B., PiantelliM. (2000) Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. International Journal of Cancer, 87, 595–600.
7.
CaiJ., ZhaoX.L., LiuA.W., NianH., ZhangS.H. (2011) Apigenin inhibits hepatoma cell growth through alteration of gene expression patterns. Phytomedicine, 18, 366–373.
8.
KimB.K., ChoA.R., ParkD.J. (2016) Enhancing oral bioavailability using preparations of apigenin-loaded W/O/W emulsions: In vitro and in vivo evaluations. Food Chemistry, 206, 85–91.
9.
MeyerH., BolarinwaA., WolframG., LinseisenJ. (2006) Bioavailability of apigenin from apiin-rich parsley in humans. Annals of Nutrition and Metabolism, 50, 167–172.
10.
WalleT. (2004) Absorption and metabolism of flavonoids. Free Radical Biology and Medicine, 36, 829–837.
11.
ManachC., ScalbertA., MorandC., RémésyC., JiménezL. (2004) Polyphenols: food sources and bioavailability. American Journal of Clinical Nutrition, 79, 727–747.
12.
HollmanP.C. (2004) Absorption, bioavailability, and metabolism of flavonoids. Pharmaceutical Biology, 42, 74–83.
13.
ManachC., WilliamsonG., MorandC., ScalbertA., RémésyC. (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. American Journal of Clinical Nutrition, 81, 230S–242S.
14.
TosettiF., FerrariN., De FloraS., AlbiniA. (2002) Angioprevention: angiogenesis is a common and key target for cancer chemopreventive agents. FASEB Journal, 16, 2–14.
15.
FolkmanJ. (2003) Angiogenesis and apoptosis. Seminars in Cancer Biology, 13, 159–167.
16.
GorczycaW., GongJ., ArdeltB., TraganosF., DarzynkiewiczZ. (1993) The cell cycle-related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Research, 53, 3186–3192.
17.
XiaoD., ZhuS.P., GuZ.L. (1997) Quercetin induced apoptosis in human leukemia HL-60 cell. Acta Pharmacologica Sinica, 18, 280–283.
18.
YinF., GiulianoA.E., Van HerleA.J. (1999) Signal pathways involved in apigenin inhibition of growth and induction of apoptosis of human anaplastic thyroid cancer cells (ARO). Anticancer Research, 19, 4297–4303.
19.
AhnM.R., KunimasaK., OhtaT., KumazawaS., KamihiraM., KajiK., UtoY., HoriH., NagasawaH., NakayamaT. (2007) Suppression of tumor-induced angiogenesis by Brazilian propolis: Major component artepillin C inhibits in vitro tube formation and endothelial cell proliferation. Cancer Letters, 252, 235–243.
20.
OikawaT., HirotaniK., NakamuraO., ShudoK., HiragunA., IwaguchiT. (1989) A highly potent antiangiogenic activity of retinoids. Cancer Letters, 48, 157–162.
21.
ParkS.I., OhtaT., KumazawaS., JunM., AhnM.R. (2014) Korean propolis suppresses angiogenesis through inhibition of tube formation and endothelial cell proliferation. Natural Product Communications, 9, 555–560.
22.
OhtaT., EguchiR., SuzukiA., MiyakazeS., AyuzawaR., KajiK. (2007) Hypoxia-induced apoptosis and tube breakdown are regulated by p38 MAPK but not by caspase cascade in an in vitro capillary model composed of human endothelial cells. Journal of Cellular Physiology, 211, 673–681.
